SM

Sabby Management Portfolio holdings

AUM $12M
1-Year Est. Return 79.04%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
-79.04%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$213M
AUM Growth
+$45.1M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
183
New
Increased
Reduced
Closed

Top Buys

1
+$13.1M
2
+$10.3M
3
+$7.29M
4
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$6.72M
5
GILD icon
Gilead Sciences
GILD
+$6.04M

Top Sells

1
+$22.4M
2
+$9.33M
3
+$5.53M
4
AEGR
Aegerion Pharmaceuticals
AEGR
+$4.82M
5
TEVA icon
Teva Pharmaceuticals
TEVA
+$4.69M

Sector Composition

1 Healthcare 87.73%
2 Energy 1.29%
3 Communication Services 0%
4 Materials 0%
5 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$19.3M 9.07%
364,741
-101,571
2
$11.8M 5.54%
+66
3
$11.3M 5.3%
463,146
-93,867
4
$11M 5.17%
155,073
+77,073
5
$8.78M 4.13%
+828
6
$8.46M 3.98%
352,100
-155,600
7
$7.75M 3.64%
+831,237
8
$6.23M 2.93%
+131,235
9
$6.02M 2.83%
+34,058
10
$5.5M 2.59%
+354,000
11
$5.22M 2.46%
+42,311
12
$5.16M 2.43%
+17,191
13
$4.69M 2.21%
405,946
+168,946
14
$4.64M 2.19%
+38,630
15
$4.34M 2.04%
+3,345
16
$4.24M 2%
+3,171
17
$4.19M 1.97%
+150,553
18
$3.94M 1.86%
+33,333
19
$3.44M 1.62%
+151,220
20
$3.21M 1.51%
+177,265
21
$3.19M 1.5%
122
+70
22
$2.9M 1.37%
+98,500
23
– –
0
24
$2.86M 1.35%
+167,999
25
$2.84M 1.33%
+341,810
1
2 3 4 5